DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: Regeneron Pharmaceuticals

News

Regeneron Invests $1.8 Billion in Tarrytown

10.08.2021 -

US biotech Regeneron is planning to invest roughly $1.8 billion over six years to expand its research, preclinical manufacturing and support facilities at its Westchester...

News

Bayer and Regeneron Explore Combination Eye Treatment

31.03.2016 - Bayer and US drug developer Regeneron Pharmaceuticals have agreed to jointly develop a combination therapy of the angiopoietin2 (Ang2) antibody nesvacumab and vascular endothelial...

News

Regeneron and Sanofi to Appeal Patent Decision

18.03.2016 - Drugmakers Regeneron Pharmaceuticals and Sanofi have said they will appeal a decision by a US federal jury that their cholesterol drug Praluent (alirocumab) infringes patents owned...

News

Amgen Gets Nod for New Cholesterol Drug

31.08.2015 - Amgen has won US Food and Drug Administration (FDA) approval for Repatha, the second medicine in a new class of biologics recently greenlighted by the agency and claimed to reduce...

News

Lucentis and Avastin Said to Have Similar Side Effects

16.09.2014 - Roche's cancer drug Avastin as a cheaper treatment for wet age-related macular degeneration (wAMD), a leading cause of blindness in the elderly, does not appear to increase deaths...

News

Cholesterol Drug Halves Heart Attack and Stroke in Early Test

02.09.2014 - An experimental cholesterol-lowering drug, alirocumab, from Sanofi and Regeneron Pharmaceuticals roughly cut in half the number of heart attacks and strokes in a clinical trial...

News

Bayer and Regeneron Widen Wet AMD Partnership

14.01.2014 - Bayer HealthCare of Germany and its U.S. drug development partner Regeneron Pharmaceuticals have agreed to collaborate on Derived Growth Factor Receptor Beta (PDGFR-β) as a...

News

Bayer’s Eylea AMD Drug Hits Cost Evaluation Hurdle

06.01.2014 - Bayer HealthCare has hit a stumbling block in the sales campaign for its new drug Eylea (aflibercept), or VEGF Trap-Eye, recommended for treatment of age-related wet macula...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.